Summary Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a biopharmaceutical company that develops innovation therapies for inflammatory skin conditions and aesthetic conditions. It offers topical by design or low systemic exposure technology platform for local treatment Photoparticle therapy (PPT) platform for treating acne, pigmentation and unwanted hair growth. The company’s pipeline portfolio includes therapies such as SNA 120 for psoriasis and pruritus, SNA 001 for acne vulgaris in phase II stage; and SNA 125 for atopic dermatitis, psoriasis and pruritus in pre-clinical stage; and other therapies in pre-clinical phase. Sienna Biopharmaceuticals is headquartered in Westlake Village, California, the US. Sienna Biopharmaceuticals Inc (SNNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal... Research Beam Model: Research Beam Product ID: 1995402 250 USD New
Sienna Biopharmaceuticals Inc (SNNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Sienna Biopharmaceuticals Inc (SNNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : August   2017
  • Pages : 27
  • Publisher : GlobalData
 
 
 
Summary

Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a biopharmaceutical company that develops innovation therapies for inflammatory skin conditions and aesthetic conditions. It offers topical by design or low systemic exposure technology platform for local treatment Photoparticle therapy (PPT) platform for treating acne, pigmentation and unwanted hair growth. The company’s pipeline portfolio includes therapies such as SNA 120 for psoriasis and pruritus, SNA 001 for acne vulgaris in phase II stage; and SNA 125 for atopic dermatitis, psoriasis and pruritus in pre-clinical stage; and other therapies in pre-clinical phase. Sienna Biopharmaceuticals is headquartered in Westlake Village, California, the US.

Sienna Biopharmaceuticals Inc (SNNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sienna Biopharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Sienna Biopharma Raises USD40 million in Series B Financing 12
Sienna Biopharma Raises Additional USD12 Million in Series A Financing 13
Sienna Biopharma Raises USD34 Million in Series A Financing 14
Sienna Biopharma Raises USD18.4 Million in Financing 15
Creabilis Secures US$20 Million In Series B Financing 16
Licensing Agreements 17
Sienna Biopharma Amends its Licensing Agreement with nanoComposix 17
Equity Offering 18
Sienna Biopharma Raises USD74.7 Million in IPO 18
Sienna Biopharma Raises USD0.6 Million in Private Placement of Shares 20
Acquisition 21
Sienna Biopharmaceuticals Acquires Creabilis 21
Sienna Biopharmaceuticals Inc - Key Competitors 22
Sienna Biopharmaceuticals Inc - Key Employees 23
Sienna Biopharmaceuticals Inc - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Jun 14, 2017: Sienna Biopharmaceuticals Appoints Erle Mast, Former CFO and Co-Founder of Clovis Oncology, to Board of Directors 25
Mar 24, 2017: Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sienna Biopharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Sienna Biopharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sienna Biopharma Raises USD40 million in Series B Financing 12
Sienna Biopharma Raises Additional USD12 Million in Series A Financing 13
Sienna Biopharma Raises USD34 Million in Series A Financing 14
Sienna Biopharma Raises USD18.4 Million in Financing 15
Creabilis Secures US$20 Million In Series B Financing 16
Sienna Biopharma Amends its Licensing Agreement with nanoComposix 17
Sienna Biopharma Raises USD74.7 Million in IPO 18
Sienna Biopharma Raises USD0.6 Million in Private Placement of Shares 20
Sienna Biopharmaceuticals Acquires Creabilis 21
Sienna Biopharmaceuticals Inc, Key Competitors 22
Sienna Biopharmaceuticals Inc, Key Employees 23
Sienna Biopharmaceuticals Inc, Subsidiaries 24
List of Figures
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sienna Biopharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter